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D Herrmann1, T Intemann1, F Lauria2, S Mårild3, D Molnár4, LA Moreno5, I Sioen6, M Tornaritis7, T Veidebaum8, I Pigeot1,9
and W Ahrens1,9 on behalf of the IDEFICS consortium
BACKGROUND/OBJECTIVE: Quantitative ultrasound measurements and bone metabolic markers can help to monitor bone health
and to detect impaired skeletal development. Population-based reference values for children may serve as a basis for preventive
measures to reduce the risk of osteoporosis and osteoporotic fractures in later life. This is the ﬁrst paper providing age-, sex- and
height-speciﬁc reference values for bone stiffness index (SI) and serum carboxy-terminal cross-linking telopeptide of type I collagen
(CTX) in healthy, apparently prepubertal children.
SUBJECTS/METHODS: In the population-based IDEFICS baseline survey (2007–2008) and follow-up (2009–2010), 18 745 children from
eight European countries were newly recruited. A total of 10 791 2–10.9-year-old and 1646 3–8.9-year-old healthy children provided
data on SI of the right and left calcaneus and serum CTX, respectively. Furthermore, height and weight were measured. Percentile
curves were calculated using the General Additive Model for Location Scale and Shape (GAMLSS) to model the distribution of SI and
CTX depending on multiple covariates while accounting for dispersion, skewness, and the kurtosis of this distribution.
RESULTS: SI was negatively associated with age and height in children aged 2–5 years, whereas a positive association was
observed in children aged 6–10 years. The dip in SI occurred at older age for higher SI percentiles and was observed earlier in taller
children than in smaller children. The CTX reference curves showed a linear-positive association with age and height. No major sex
differences were observed for the SI and CTX reference values.
CONCLUSION: These reference data lay the ground to evaluate bone growth and metabolism in prepubertal children in
epidemiological and clinical settings. They may also inform clinical practice to monitor skeletal development and to assess adverse
drug reactions during medical treatments.
International Journal of Obesity (2014) 38, S76–S85; doi:10.1038/ijo.2014.138
INTRODUCTION
Unhealthy lifestyle habits, like physical inactivity may hamper the
child attaining its genetically programmed peak bone mass.
Moreover, an impaired skeletal development in early life can be
caused by an underlying genetically or lifestyle-related disorder,
for example, adiposity as well as by certain medical treatments.1–4
This may in return increase the risk of osteoporosis and
osteoporotic fractures later in life.5–7 Previous studies reported
that children having a low bone mineral density in prepuberty
remain to have a low bone mineral density in adolescence.8–10 In
contrast, other studies showed that an impaired skeletal devel-
opment during childhood may be largely reversible when treating
underlying diseases.11–13
Age- and sex-speciﬁc bone reference values can help to assess
skeletal development during childhood and to compare the bone
health status of a child with that of a healthy population having the
same age, sex and ethnicity. Thus, deviations from a normal skeletal
development may be identiﬁed in an early stage. Until now,
paediatric reference data have mainly been used for diagnosing
poor bone acquisition in children who are suffering from multiple
fractures, diseases or receiving medical treatments affecting bone
metabolism.11,14 Bone reference data may be not only a diagnostic
tool for children with bone diseases15 but may also serve to monitor
apparently healthy subjects and to identify those who may beneﬁt
from speciﬁc interventions to improve bone health.
Only few studies established paediatric reference values for
physical bone measurements. Reference values are mainly
reported for bone mineral content and areal bone mineral density
(aBMD) assessed with dual-energy X-ray absorptiometry (DXA).
These reference data are mostly based on Asian, mixed American
and Caucasian populations and are predominantly available for
children above the age of 6 years.10,14,16–21 Several studies
reported limitations of DXA to assess bone status in growing
individuals. Especially, the use of aBMD results in an artiﬁcial
underestimation of the bone status in short people and an
overestimation in tall people due to its areal but not volumetric
measurement. This measure is size dependant owing to its two-
dimensional image projection of a three-dimensional structure.
That is, it does not account for depth or size and hence, it is not
able to predict the ‘true density’ of the bone.16,22 Furthermore,
DXA does not distinguish between trabecular and cortical bone. It
provides only little information on bone geometry and trabecular
microarchitecture. Moreover, there is no evidence that aBMD is
predictive for fracture risk in children.23
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Quantitative ultrasound (QUS) may be a more appropriate
method to monitor skeletal development in children compared to
DXA. QUS is a quick, cost-efﬁcient and radiation-free method to
evaluate bone stiffness that indicates density, structure and
composition of the bone.24,25 Especially, the calcaneus was found
to be a reliable location to assess bone status. The calcaneus
consists of 90% trabecular bone that shows a high metabolic rate.
The bone microarchitecture is similar to that of the lumbar spine
and the femoral neck, which are major body sites for diagnosing
osteoporosis.24 Besides the difference between QUS and DXA
measurements assessing bone status, bone stiffness showed good
correlations with aBMD assessed by DXA in adults25 and
children.26,27 Furthermore, it revealed to be highly prognostic
with regard to bone fractures in adults28 and proved to be a valid
measure for the risk for osteopenia in young patients.27 Up to
now, QUS references were established mainly for adults but are
barely available for children and adolescents.20,24
According to the recommendation of the International Society
for Clinical Densitometry, a combined assessment of physical
measures and biochemical bone metabolic markers is useful to
identify a reduced skeletal development in children.11,15,29
Physical bone measurements predict the actual bone status. Bone
metabolic markers, such as osteocalcin or collagen cross-linked
telopeptides indicate reduced or increased bone turnover
processes. These clinical parameters may be useful to monitor
skeletal development, as they can be repeated at much shorter
intervals. Hence, they allow detection of acute effects caused by
diseases or treatments long time before changes in bone mass
occur.15 Reference data on these bone metabolic markers are rare
in children and are mostly limited to selected clinical populations
with a limited age range.11,15,30,31
In the IDEFICS (Identiﬁcation and prevention of Dietary- and
lifestyle-induced health Effects in Children and InfantS) study, bone
stiffness index (SI) was measured using QUS in a large European
child cohort. Serum carboxy-terminal cross-linking telopeptide of
type I collagen (β-CrossLaps, CTX) as an indicator for bone resorption
and bone turnover was measured in a case-control subsample.
The aim of the present study was to provide age- and sex-
speciﬁc reference values for SI and CTX adjusted for body size for
apparently prepubertal children based on an European sample of
18 745 healthy children who participated in the IDEFICS study. To
calculate reference values and percentile curves, the General
Additive Model for Location Scale and Shape (GAMLSS) was used
to model the distribution of SI and CTX depending on multiple
covariates while accounting for dispersion, skewness, and
particularly the kurtosis of this distribution.32,33
MATERIALS AND METHODS
Analysis group
In the population-based IDEFICS baseline survey (2007–2008, T0) and
follow-up (2009–2010, T1) 18 745 children aged 2–10.9 from eight
European countries (Belgium, Cyprus, Estonia, Germany, Hungary, Italy,
Spain, Sweden) were newly recruited and examined. The IDEFICS study is
one of the current largest prospective European child cohorts.34 Besides
the comprehensive IDEFICS examination programme, heel QUS was
applied in a subsample.
Written informed consent was obtained from the parents and each child
was asked to give verbal assent immediately before examination.
Participants were free to omit speciﬁc modules like blood drawing. In
each country, the participating centres obtained ethical approval by their
responsible authority. The whole examination programme of the IDEFICS
study as well as further information regarding the study design were
recently described in detail.34–36
Figure 1 summarises all exclusion criteria as well as the number of
included and excluded children of the ﬁnal SI analysis group. A total of
11 414 children having their ﬁrst QUS measurement in T0 (N= 7539) or
having no QUS in T0 but in T1 (N= 2714) as well as all newly recruited
children with QUS measurement in T1 (N= 1161) were considered for the
current analysis. Thirty-three children from T0 having no QUS in T0 but in T1
had an age above 10.9 years at T1 and were therefore excluded from the
present analysis.
We conducted a small reliability study based on ﬁve of eight Achilles
devices that were used within the IDEFICS study to investigate
measurement errors and outliers of SI values. QUS measurements were
performed in 91 subjects and repeated three times per foot and device.
Accounting for repeated measurements, a multilevel regression was
performed, but showed no differences in SI values between the three
repeated measurements and between measurements at the left and right
foot. However, a signiﬁcant deviation of the SI values between the devices
was observed varying within a range of 0–5 SI units on average. A
signiﬁcant discrepancy between the devices was also found for the
absolute SI difference of the left and right foot. Based on these results,
the 97th percentile of the absolute difference between the SI values of the
right and left foot was considered to reﬂect unreliable measurements.
According to this quality criterion, 341 children were excluded from the
present analysis. Decreased birth weight associated with premature birth
and growth retardation causes reduced bone accretion. Hence, 14 children
with a birth weight o1000 g were excluded according to the ICD-10
criterion on ‘extremely low birth weight’.37,38 Moreover, diseases and
medical treatments that directly affect bone metabolism were identiﬁed by
a health and medical history questionnaire. Diseases and treatments were
categorized according to the ICD-10 and ATC coding, respectively (see
Table 1).37,39 We excluded 111 children with a disease and 115 children
receiving medical treatments that directly impair bone metabolism.5,15
Finally, nine children were excluded because their measurement values
exceeded ﬁve s.d. values of the age- and sex-speciﬁc height z-score
according to International Obesity Task Force.40 Thus, the ﬁnal analysis
group consisted of 10 791 children for SI (see Figure 1).
Besides other bone metabolic markers, serum CTX has been analysed in
a subsample drawn from the IDEFICS cohort for a case-control study. SI was
chosen as an indicator for bone health. Within this case-control study,
children between 2 and 9.9 years who had an SI below the 15th age- and
sex-speciﬁc percentile of all IDEFICS children were eligible and classiﬁed as
cases having low SI. Controls were randomly selected from the remaining
cohort and matched to cases by age, sex and study centre. A total of 1646
children aged 3.0–8.9 years provided sufﬁcient data on CTX and SI and
were considered for the CTX analysis group, applying the same exclusion
criteria as for the SI analysis group (see Table 1 and Figure 2).
Measurements
QUS (Lunar Achilles Insight, GE Healthcare, Milwaukee, WI, USA)41 was used
to measure SI on the right and left foot. Both measurements were used to
calculate the mean, which was considered for calculating the present
reference values. In a subsample, the raw QUS measurements broadband
ultrasound attenuation and speed of sound were measured. Reference
values of these parameters will be considered in further publications. For
standardised measurements, the child was asked to sit barefoot on a stable
chair directly in front of the device. The leg was positioned so that the foot
and calf were aligned with the foot positioner. The foot was positioned
using an adapter for children’s feet to put the calcaneus in focus. The study
nurse made sure that the foot was ﬂat and positioned ﬁrmly against the
bottom of the footplate and that the child was not moving during
the measurement. When changing the measured foot, the position on the
chair had to be adjusted. Quality control was performed weekly, using the
implemented quality assurance test of Achilles Insight.41
For laboratory analysis of CTX, blood samples were drawn in the morning
(between 8 a.m. and 10 a.m.) after an overnight fast. Blood samples were
centrifuged (2100 g, 10min, room temperature) within 2 h of venipuncture,
frozen within about 4 h after withdrawal and stored at − 80 °C. Serum CTX
(ngml− 1) was determined by electrochemiluminescence assay using Roche,
ECLIA Modular E17 (Roche, Diagnostics, Mannheim, Germany).
Body height (Seca 225 stadiometer, seca, Birmingham, UK) and body
weight (Tanita BC 420 SMA, Tanita Europe, Sindelﬁngen, Germany) were
measured to the nearest 0.1 cm and 0.1 kg, respectively. Body mass index
(kgm−2) as well as z-scores of height, weight and body mass index were
calculated according to the British 1990 growth reference.40 Moreover,
children were categorised as thin (grade 1–3), normal weight, overweight
and obese using the International Obesity Task Force criteria.42 Leg-to-leg
bioelectrical impedance was measured with the Tanita scale and used to
calculate fat-free mass based on the Tyrrell formula.43 fat-free mass index
(kgm−2) was calculated according to Wells and Cole.44
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Statistical analyses
For both analysis groups, mean and s.d. of SI and CTX as well as of age,
height and weight of 1-year age groups were calculated to describe study
characteristics. In particular, percentile values of SI and CTX were calculated
as a function of different covariates, for example, age, height or weight,
stratiﬁed by sex using the GAMLSS method.
Due to the case-control design, the CTX sample included a high
percentage (50%) of cases with a low SI that was deﬁned below the 15th
age- and sex-speciﬁc SI percentiles. To correct the GAMLSS analyses for
oversampling of cases against controls, we used weights for cases and
controls in the GAMLSS models calculating percentile values for CTX. These
weights were based on the original distribution in the study sample (cases:
15%; controls: 85%).
The GAMLSS method is an extension of the LMS method that models
three parameters depending on one explanatory variable: (M) accounts for
the median of the outcome variable and the coefﬁcient of variation; (S)
accounts for the variation around the mean and adjusts for non-uniform
dispersion, while the skewness (L) accounts for the deviation from a
normal distribution using a Box–Cox transformation. The GAMLSS method
is able to consider distributions with varying kurtosis and multiple
covariates in the model. We used the gamlss package (version 4.2–6) of
the statistical software R (version 3.0.1).45 Different distributions, that is, the
Box–Cox power exponential, the Box–Cox transformation or the Box–Cox
Cole and Green distribution were ﬁtted to the observed distribution of SI.
The normal, the power exponential and the t-family distribution were ﬁtted
to the observed and weighted distribution of CTX.
Depending on the potential covariates (for example, age, height, height
z-score, weight, weight z-score, body mass index, body mass index z-score
and fat-free mass index), distribution parameters were modelled either as a
constant, as a linear function or as a cubic spline. To identify the best
combination of these covariates, different combinations were investigated
to choose the best model. Goodness of ﬁt for both dependant variables SI
and CTX was assessed based on the Bayesian Information Criterion, Q–Q
plots and worm plots.46 The best model for SI and CTX included the
covariates, age and height. For modelling SI percentiles, no adjustment for
kurtosis was needed. Therefore, the ﬁnal SI model for both sexes
considered a Box–Cox Cole and Green distribution modelling μ as a linear
function of age and a cubic spline of height, log(σ) and ν as cubic splines of
height only. The ﬁnal model for CTX considered a normal distribution
modelling μ as a linear function of age and height and log(σ) as constant in
both sexes. Figure 3, in which the Q–Q plots of residuals for SI and CTX in
boys are depicted, shows that the derived percentiles ﬁt the data well. The
same was observed for girls (data not shown).
Final models of SI and CTX were used to calculate percentile values for
the 1st, 3rd, 10th, 25th, 50th, 75th, 90th, 97th and 99th percentiles.33,45 To
present values of the calculated percentiles, tables were presented for
1-year age groups and seven height percentiles (3rd, 10th, 25th, 50th, 75th,
90th and 97th). Further age- and sex-speciﬁc reference values of the 5th,
15th, 85th and 95th percentiles of SI and CTX will be provided in
(Supplementary Tables A–D). In the following, children aged 2–o6 years
and 6–o11 years will be referred to as preschool and primary school
children, respectively.
RESULTS
Characteristics of the analysis groups for SI and CTX
Tables 2 and 3 present the sex-speciﬁc characteristics of the SI and
CTX analysis groups, stratiﬁed by 1-year age groups, respectively.
The SI analysis group included children aged 2–10.9 years and
consisted of 5412 boys and 5379 girls. Boys and girls had similar
average SI values. Although, preschool girls tended to have
slightly higher SI values compared with boys, the primary school
girls had marginally lower SI values. Age-speciﬁc average body
height and weight were similar in boys and girls (see Table 2).
The CTX analysis group aged 3–8.9 years consisted of 857 boys
and 789 girls. Within 1-year age groups, CTX values differed by
11 414
11 381
11 040
11 026
10 915
10 800
10 791
Exclusion Criteria and number
of excluded children
Missing SI (N=7331)
Birth weight <1000g (N=14)
Diseases (N=111)
Treatment or medication
(N=115)
Height z-score > 5th s.d. (N=9)
16 228 2517
18 745
Baseline survey
(2007 – 2008)
Newly recruited
children
(2009 – 2010)
T0 children older than 10.9
years with QUS measurement
at T1 (N=33)
Measurement error in SI
(N=341)
Figure 1. Number of included and excluded children per exclusion
criteria for the SI analysis group from the IDEFICS population.
Table 1. Frequency of excluded disorders and medical treatments for
establishing the SI and CTX analysis group
Excluded
children (N)
for SI
Excluded
children (N)
for CTX
Disease
Cancer 13 2
Disorders of thyroid gland 13 1
Endocrine disorders (for example, lack
of growth hormone)
8 —
Vitamin D deﬁciency /rickets
/osteomalacia
1 —
Dietary calcium deﬁciency 1 —
Cerebral palsy 12 2
Hemiplegia 1 —
Rheumatic fever 6 1
Disorders of arteries and arterioles 6 2
Renal failure/disease of kidneys 3 —
Diseases of the musculoskeletal
system
5 1
Osteochondrodysplasias 1 —
Fractures/disorders of continuity
of bone
34 5
Osteomyelitis 4 1
Other disorders of bone (for example,
osteonecrosis, Paget disease)
3 —
Sum 111 15
Medication and Treatments
Chemotherapeutics 5 1
Corticosteroids 106 9
Sex hormones 1 1
Pituitary and hypothalamic hormones
and analogues
2 —
Tetracyclines 1 1
Sum 115 12
Abbreviations: CTX, cross-linking telopeptide of type I collagen; SI,
stiffness index.
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0.01–0.07 ngml− 1 between both sexes. With increasing age,
slightly higher mean CTX values were observed in boys and girls.
Boys and girls showed similar age-speciﬁc body height and weight
values (see Table 3).
Age- and sex-speciﬁc reference percentiles for SI
Tables 4 and 5 show the 1st, 3rd, 10th, 25th, 50th, 75th, 90th, 97th
and 99th SI percentile values by 1-year age groups and height for
girls and boys, separately. Figure 4 presents sex-speciﬁc reference
curves of the 1st, 50th and 99th SI percentile by age for small,
average and tall children (that is, 3rd, 50th and 97th height
percentile).
In preschool children, SI percentiles showed a negative
association with age and height. In primary school children, a
positive association with age and height was observed. The dip in
SI occurred at an older age for higher SI percentiles and was
observed earlier in taller children than in smaller children. The
association of SI with height was inverted around the dip. In boys,
height had a smaller effect on SI after the dip compared with girls
(Figure 4 and Tables 4 and 5).
Age- and sex-speciﬁc reference percentiles for CTX
Tables 6 and 7 show the 1st, 3rd, 10th, 25th, 50th, 75th, 90th, 97th
and 99th CTX percentile values by 1-year age groups and height
for girls and boys, separately. Figure 5 presents sex-speciﬁc
reference curves of the 1st, 50th and 99th CTX percentile by age
for small, average and tall children. The CTX values showed a
linear-positive association with age and height. The impact of
height was slightly stronger in boys than in girls.
DISCUSSION
This study provides the ﬁrst sex-, age- and height-speciﬁc
reference values for calcaneal SI and serum CTX for 2–10.9- and
3–8.9-year-old children, respectively. Both analysis groups are
based on a population of apparently healthy European children,
where standardised QUS and blood measurements were obtained.
The main observation was the negative trend in SI with
increasing age and height in preschool children, which was
followed by a positive trend in SI with age and height in primary
school children. The negative trend of SI in preschool children may
be explained by the increased height velocity in early childhood47
where bone turnover processes may have not adequately adapted
to the growth velocity in young children. Due to the lack of bone
reference data in preschool children, no comparison with other
data can be made. The few studies in children mostly reported
data above the age of 6 years and observed a positive trend of
bone parameters with increasing age.21 Most bone reference data
in children are based on DXA measurements. But it remains
questionable to compare QUS with DXA owing to the two-
dimensional image projection of DXA measures, and the problem
that aBMD is not accounting for growth. Mathematical models
were established to calculate the volumetric BMD or bone mineral
apparent density, where height, bone area and bone width are
considered to avoid under- or overestimation of bone
status.16,18,19,22 Considering such models, a slight decline in bone
mineral apparent density of the femoral neck with increasing age
has been observed in primary school children, which is in contrast
to our ﬁndings.16,19
A comparison of our QUS reference data with other QUS
reference data should be made with caution. Most of the studies
used different methods for calculating reference values or applied
different QUS devices (for example, CUBA, Sahara, Sunlight
Omnisense) with different measures (for example, speed of sound,
broadband ultrasound attenuation) on different body sites (for
1753
1744
1742
1727
1715
1714
1646
Missing CTX (N=16 992)
Missing SI (N=9)
Birth weight < 1000g (N=2)
Diseases (N=15)
Medication or treatment 
(N=12)
Exclusion Criteria and number
of excluded children
16 228 2517
18 745
Baseline survey
(2007 – 2008)
Newly recruited
children
(2009 – 2010)
Height z-score >5th s.d. (N=1)
<3 years or ≥9 years (N=68)
Figure 2. Number of included and excluded children per exclusion
criteria for the CTX analysis group from the IDEFICS population.
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Figure 3. Q–Q plot of residuals for SI and CTX in boys.
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example, radius, phalanx) in different ethnicities.20,48–54 The few
studies that assessed calcaneal QUS in prepubertal children aged
6–10 years showed a progressive increase of broadband
ultrasound attenuation and a small or no increase of speed of
sound with age.48,50–52 Only two studies established SI reference
or normative data in children, adolescents and young adults in the
age range from 6 to 21 years. Compared with prepubertal ages,
both studies observed a stronger trend in SI with age around the
age of 12 years in girls and 14 years in boys.20,54 This increase
during puberty was also found in studies considering other QUS or
DXA bone parameters, indicating that the growth spurt started
earlier in girls than boys.14,21,50,51 In the present study, no such
spurt in SI was observed until the age of 10 years. However, our
data showed a positive trend of height in tall 10-year old girls,
which may indicate the earlier start of maturation in girls than
in boys.
The few published references and normative data on SI 20,54 and
CTX 15,55 are not informative regarding age distribution, especially
not of the more extreme percentiles, which are of interest for
clinical practice. We suggest that the lower the SI percentiles, the
more important the meaning of the increase or decrease in SI. In
other words, a difference of ﬁve SI units between age groups
would be more relevant for bone diagnostic at the 3rd SI
percentile than at the 50th percentile. For example, an increase of
ﬁve units in a 5.5-year-old girl with an SI in the 3rd percentile
would result in an improvement of SI from the 3rd to the 10th
percentile (see Table 4). The same applies to CTX.
Considering the present SI reference values, the 3rd age-speciﬁc
percentile in 5.5–10.9-year-old boys (range: 55.7–69.4) and girls
(range: 54.2–69.1) may be considered as a warning threshold for
low SI and reduced skeletal development. The pathological
meaning of these values still needs to be evaluated. Only one
study investigated SI values in children with bone disorders:
Jaworski et al.27 observed a mean SI of 50.6 ± 13.7 in eighteen 6- to
13-year old children having osteopenia. According to these
ﬁndings, our reference values for 5.5–9.5-year- old girls in the
1st age-speciﬁc SI percentile (range: 49.9–64.9) are close to this
pathological value for osteopenia. The observed range of 15 SI
units of the 1st percentile between the age of 5 and 10 years
supports the need for age-speciﬁc cut-off values of SI, for example,
for predicting osteopenia in childhood.
CTX is mainly used as a bone resorption marker in post-
menopausal women. Compared with adults, elevated CTX
concentrations of children can be explained by the high skeletal
growth velocity and rapid bone turnover.56,57 Only one study
reported reference values for the 5th, 50th and 95th percentiles
established from a smaller sample of 572 Caucasian children.
Although a different assay for analysing CTX was used in this
study, it showed similar CTX values.15 Other studies reported
different CTX values in prepubertal children. For example, Crofton
et al.55 observed a 95% reference interval (median of 0.352
ngml− 1) be1tween 0.146 and 0.818 ngml− 1 in a small study
sample of 124 Caucasian boys and girls aged 1–9 years.
These concentrations are below the reference range of our
3–8-year-old CTX study sample, which varied between 0.20
and 2.03 ngml− 1. In contrast, Ambroszkiewiki et al.58 reported
different means of CTX in 100 vegetarian (1.697 ± 0.653 ngml− 1)
and omnivorous children (1.99 ± 0.30 ngml− 1) aged 2–10 years,
which compares with a lower mean of CTX in our study group
(1.19 ± 0.27 ngml− 1). Crofton et al. and Ambroszkiewiki et al. used
a different assay for analysing CTX which may be one reason
for the differences.
To present reference values that are not affected by disturbed
skeletal development due to very low birth weight, diseases or
Table 2. Sex-speciﬁc SI, height and weight of the IDEFICS SI analysis group, stratiﬁed by 1-year age groups
Age group
(year)
Girls Boys
N Age (year)
mean± s.d.
SI
mean± s.d.
Height (cm)
mean± s.d.
Weight (kg)
mean± s.d.
N Age (year)
mean± s.d.
SI
mean± s.d.
Height (cm)
mean± s.d.
Weight (kg)
mean± s.d.
2.0–2.9 102 2.7± 0.2 84.7± 10.5 93.0± 4.1 13.9± 1.8 116 2.6± 0.2 84.6± 11.9 93.9± 4.3 14.6± 1.9
3.0–3.9 476 3.5± 0.3 82.5± 15.2 100.4± 5.1 16.0± 2.5 495 3.5± 0.3 81.7± 13.7 101.0± 4.9 16.2± 2.1
4.0–4.9 593 4.5± 0.3 82.4± 17.4 106.8± 4.7 18.1± 2.8 670 4.5± 0.3 80.2± 15.4 108.1± 5.1 18.6± 3.1
5.0–5.9 628 5.5± 0.3 80.0± 17.5 113.9± 5.3 20.7± 3.7 680 5.5± 0.3 79.1± 16.0 114.7± 5.2 21.0± 3.6
6.0–6.9 768 6.5± 0.3 76.9± 14.6 120.0± 5.5 23.4± 4.7 762 6.5± 0.3 77.8± 13.8 121.3± 5.6 24.1± 4.8
7.0–7.9 1104 7.5± 0.3 78.8± 11.9 126.7± 5.5 27.0± 5.7 1078 7.5± 0.3 80.1± 11.7 127.9± 5.8 27.8± 6.0
8.0–8.9 911 8.4± 0.3 81.1± 12.0 131.7± 5.9 30.4± 6.6 836 8.4± 0.3 82.0± 11.5 132.6± 5.8 30.5± 6.9
9.0–9.9 535 9.5± 0.3 83.8± 10.6 138.0± 6.7 34.4± 8.5 473 9.5± 0.3 84.8± 11.7 139.3± 6.4 36.0± 8.6
10.0–10.9 262 10.3± 0.3 85.8± 12.6 143.9± 6.5 39.7± 9.9 302 10.3± 0.3 87.0± 11.8 142.9± 6.4 39.3± 10.2
Abbreviations: IDEFICS, Identiﬁcation and prevention of Dietary- and lifestyle-induced health Effects in Children and InfantS; SI, stiffness index.
Table 3. Sex-speciﬁc CTX, height and weight of the IDEFICS CTX analysis group, stratiﬁed by 1-year age groups
Age group
(year)
Girls Boys
N Age (year)
mean± s.d.
CTX (ng ml− 1)
mean± s.d.
Height (cm)
mean± s.d.
Weight (kg)
mean± s.d.
N Age (year)
mean± s.d.
CTX (ng/ml)
mean± s.d.
Height (cm)
mean± s.d.
Weight (kg)
mean± s.d.
3.0–3.9 109 3.5± 0.3 1.06± 0.24 101.1± 4.8 16.2± 2.9 94 3.6± 0.3 1.09± 0.26 102.1± 4.9 16.7± 2.5
4.0–4.9 117 4.4± 0.3 1.19± 0.28 107.2± 4.2 18.2± 2.6 152 4.5± 0.3 1.13± 0.28 108.2± 4.7 18.5± 2.6
5.0–5.9 103 5.4± 0.3 1.23± 0.30 113.9± 5.2 20.9± 3.8 111 5.4± 0.3 1.17± 0.25 114.7± 4.9 20.5± 2.8
6.0–6.9 129 6.5± 0.3 1.20± 0.27 120.1± 5.0 22.8± 5.0 154 6.5± 0.3 1.21± 0.25 122.0± 5.2 24.0± 4.6
7.0–7.9 186 7.5± 0.3 1.24± 0.27 126.2± 5.3 26.2± 5.2 198 7.5± 0.3 1.22± 0.26 127.4± 6.0 27.3± 6.0
8.0–8.9 145 8.4± 0.3 1.25± 0.29 130.9± 5.6 29.0± 6.2 148 8.4± 0.3 1.25± 0.25 131.6± 6.0 28.8± 6.2
Abbreviations: CTX, cross-linking telopeptide of type I collagen; IDEFICS, Identiﬁcation and prevention of Dietary- and lifestyle-induced health Effects in
Children and InfantS; SI, stiffness index.
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Table 4. SI percentile values (P) for calcaneal QUS by 1-year age groups and age-speciﬁc height percentiles (3rd, 10th, 25th, 50th, 75th, 90th and
97th) in girls
Age (year) Height (cm) Stiffness index percentiles—girls
P1 P3 P10 P25 P50 P75 P90 P97 P99
2.5 85 60.2 65.8 72.9 79.8 87.0 93.9 99.9 105.7 109.8
2.5 87 58.5 64.2 71.5 78.6 86.3 93.6 100.0 106.2 110.7
2.5 89 57.0 62.7 70.2 77.5 85.5 93.3 100.2 106.8 111.7
2.5 92 54.7 60.5 68.1 75.8 84.4 92.9 100.5 108.0 113.6
2.5 94 53.4 59.1 66.8 74.7 83.6 92.6 100.8 109.0 115.2
2.5 97 51.7 57.2 64.8 73.0 82.4 92.2 101.4 110.7 117.9
2.5 100 50.3 55.5 63.0 71.2 81.0 91.6 101.9 112.7 121.1
3.5 92 55.2 60.9 68.6 76.4 85.0 93.6 101.3 108.9 114.5
3.5 95 53.2 58.9 66.6 74.7 83.9 93.2 101.8 110.4 116.9
3.5 97 52.1 57.6 65.4 73.5 83.0 92.9 102.2 111.6 118.9
3.5 100 50.7 56.0 63.5 71.8 81.7 92.4 102.7 113.6 122.1
3.5 102 50.0 55.0 62.4 70.6 80.7 91.9 103.0 114.8 124.4
3.5 105 49.2 53.9 60.9 68.9 79.1 90.9 102.9 116.5 127.7
3.5 108 49.1 53.3 59.8 67.5 77.5 89.5 102.3 117.4 130.5
4.5 98 52.0 57.5 65.3 73.5 83.3 93.5 103.2 113.2 120.9
4.5 101 50.7 55.9 63.4 71.8 81.9 92.9 103.7 115.2 124.2
4.5 104 49.8 54.7 61.9 70.1 80.3 92.0 103.9 116.9 127.7
4.5 107 49.5 53.9 60.6 68.5 78.7 90.7 103.5 118.2 130.8
4.5 110 49.8 53.8 59.9 67.3 77.1 89.1 102.4 118.5 133.0
4.5 113 50.6 54.2 59.8 66.5 75.7 87.2 100.5 117.4 133.4
4.5 116 51.7 55.0 60.1 66.2 74.7 85.5 98.1 114.6 130.8
5.5 104 50.2 55.1 62.4 70.6 81.0 92.8 104.7 117.9 128.7
5.5 108 49.9 54.2 60.9 68.6 78.8 91.0 104.1 119.4 132.8
5.5 111 50.4 54.3 60.4 67.6 77.3 89.3 102.7 119.3 134.5
5.5 114 51.4 54.9 60.4 67.0 76.0 87.4 100.6 117.7 134.0
5.5 117 52.6 55.8 60.8 66.8 75.1 85.7 98.1 114.3 130.3
5.5 120 53.8 56.9 61.5 67.1 74.8 84.4 95.5 110.0 124.0
5.5 123 55.2 58.1 62.6 67.8 74.9 83.7 93.6 106.1 117.8
6.5 110 50.6 54.7 61.0 68.5 78.4 90.6 104.2 120.5 135.3
6.5 113 51.5 55.2 60.8 67.7 77.0 88.8 102.3 119.4 135.7
6.5 117 53.1 56.3 61.3 67.4 75.8 86.4 98.9 115.3 131.5
6.5 120 54.3 57.4 62.1 67.7 75.4 85.1 96.4 110.9 125.1
6.5 123 55.7 58.6 63.1 68.5 75.6 84.4 94.4 107.0 118.9
6.5 127 57.7 60.5 64.8 69.8 76.4 84.4 93.1 103.8 113.5
6.5 130 59.1 61.9 66.1 71.0 77.4 85.0 93.2 103.0 111.6
7.5 115 52.7 56.2 61.5 68.0 77.0 88.3 101.6 118.8 135.5
7.5 119 54.4 57.5 62.3 68.2 76.1 86.3 98.0 113.4 128.5
7.5 123 56.2 59.2 63.7 69.1 76.2 85.1 95.2 107.9 119.9
7.5 126 57.7 60.6 64.9 70.1 76.8 85.0 94.1 105.3 115.5
7.5 130 59.6 62.4 66.7 71.6 78.1 85.7 94.0 103.8 112.6
7.5 133 60.8 63.6 67.9 72.8 79.2 86.6 94.6 104.0 112.1
7.5 137 62.0 64.9 69.3 74.3 80.6 88.0 95.9 104.9 112.6
8.5 120 55.3 58.4 63.2 68.9 76.7 86.6 98.1 112.9 127.3
8.5 124 57.2 60.1 64.6 70.0 77.0 85.8 95.6 107.8 119.2
8.5 128 59.2 62.0 66.4 71.4 78.0 86.0 94.7 105.2 114.6
8.5 132 60.9 63.8 68.1 73.1 79.5 87.0 95.2 104.7 113.1
8.5 136 62.2 65.2 69.5 74.5 80.9 88.4 96.3 105.5 113.4
8.5 139 62.9 65.9 70.4 75.5 82.0 89.5 97.3 106.4 114.1
8.5 143 63.4 66.6 71.2 76.5 83.3 91.0 99.0 108.1 115.8
9.5 125 58.2 61.1 65.6 70.9 77.9 86.5 96.0 107.8 118.8
9.5 130 60.6 63.5 67.8 72.9 79.4 87.2 95.6 105.6 114.5
9.5 134 62.1 65.1 69.4 74.4 80.9 88.4 96.5 105.9 114.0
9.5 138 63.2 66.2 70.7 75.8 82.3 89.9 97.8 106.9 114.7
9.5 142 63.8 67.0 71.6 76.9 83.6 91.3 99.3 108.5 116.2
9.5 145 64.0 67.3 72.2 77.6 84.6 92.5 100.7 110.0 117.8
9.5 149 64.0 67.5 72.7 78.5 85.8 94.1 102.7 112.2 120.2
10.5 130 61.1 64.0 68.4 73.5 80.1 87.9 96.4 106.5 115.5
10.5 135 63.0 65.9 70.3 75.4 81.9 89.5 97.6 107.0 115.1
10.5 140 64.1 67.2 71.8 77.0 83.6 91.3 99.3 108.5 116.3
10.5 144 64.5 67.7 72.6 78.0 84.9 92.8 101.0 110.3 118.1
10.5 148 64.6 68.0 73.1 78.9 86.2 94.5 103.0 112.5 120.5
10.5 152 64.4 68.1 73.6 79.7 87.4 96.2 105.0 114.9 123.0
10.5 156 64.0 68.0 74.0 80.6 88.7 97.9 107.1 117.2 125.5
Abbreviations: QUS, quantitative ultrasound; SI, stiffness index.
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Table 5. SI percentile values (P) for calcaneal quantitative ultrasound by 1-year age groups and age-speciﬁc height percentiles (3rd, 10th, 25th, 50th,
75th, 90th and 97th) in boys
Age (year) Height (cm) Stiffness index percentiles—boys
P1 P3 P10 P25 P50 P75 P90 P97 P99
2.5 85 63.0 68.6 75.7 82.4 89.4 95.9 101.6 107.0 110.8
2.5 88 60.4 66.0 73.2 80.1 87.5 94.5 100.7 106.6 110.8
2.5 91 57.9 63.4 70.6 77.8 85.6 93.2 99.9 106.4 111.2
2.5 93 56.3 61.7 69.0 76.3 84.3 92.3 99.4 106.4 111.6
2.5 96 54.1 59.3 66.5 74.0 82.4 90.9 98.7 106.6 112.4
2.5 98 52.8 57.9 65.0 72.5 81.1 90.0 98.3 106.8 113.2
2.5 101 51.1 55.9 62.8 70.3 79.2 88.7 97.8 107.3 114.7
3.5 92 58.1 63.6 71.0 78.4 86.4 94.3 101.4 108.2 113.3
3.5 95 55.8 61.2 68.5 76.1 84.5 93.0 100.7 108.4 114.1
3.5 98 53.7 58.9 66.2 73.8 82.6 91.7 100.2 108.7 115.3
3.5 101 52.1 57.0 64.0 71.6 80.7 90.4 99.6 109.3 116.9
3.5 103 51.2 55.9 62.7 70.3 79.4 89.5 99.3 109.8 118.1
3.5 106 50.2 54.6 61.1 68.4 77.6 88.0 98.6 110.4 120.0
3.5 109 49.8 53.8 59.8 66.8 75.8 86.5 97.7 110.7 121.8
4.5 99 54.1 59.3 66.6 74.4 83.4 92.9 101.8 110.9 117.9
4.5 102 52.5 57.5 64.5 72.3 81.5 91.6 101.3 111.6 119.6
4.5 105 51.5 56.0 62.7 70.3 79.7 90.2 100.8 112.3 121.6
4.5 108 50.9 55.1 61.4 68.6 77.9 88.7 100 112.8 123.6
4.5 111 50.7 54.6 60.4 67.2 76.2 87.1 98.7 112.6 124.8
4.5 114 51.0 54.5 59.9 66.3 74.9 85.3 96.9 111.1 124.0
4.5 117 51.7 55.0 60.0 65.9 73.9 83.7 94.7 108.4 121.1
5.5 105 52.4 57.1 63.9 71.6 81.2 91.9 102.6 114.4 123.9
5.5 108 51.8 56.1 62.5 69.9 79.4 90.4 101.9 115.0 126.0
5.5 111 51.7 55.6 61.6 68.6 77.7 88.8 100.7 114.8 127.2
5.5 115 52.2 55.7 61.1 67.5 76.0 86.4 98.1 112.5 125.7
5.5 118 53.1 56.3 61.3 67.2 75.1 84.9 95.9 109.6 122.2
5.5 121 54.1 57.2 61.8 67.4 74.7 83.8 93.9 106.4 118.0
5.5 125 55.7 58.6 63.0 68.1 74.9 83.1 92.2 103.2 113.3
6.5 111 52.7 56.7 62.8 69.9 79.2 90.5 102.6 117.0 129.7
6.5 115 53.2 56.8 62.3 68.8 77.5 88.1 100.1 114.7 128.2
6.5 118 54.1 57.4 62.5 68.5 76.6 86.6 97.8 111.7 124.7
6.5 121 55.2 58.3 63.1 68.7 76.2 85.4 95.8 108.5 120.3
6.5 125 56.8 59.7 64.2 69.5 76.4 84.8 94.0 105.3 115.5
6.5 128 57.9 60.8 65.2 70.2 76.9 84.8 93.5 103.9 113.3
6.5 132 59.2 62.1 66.3 71.3 77.7 85.3 93.5 103.2 111.8
7.5 117 54.8 58.3 63.6 69.9 78.3 88.8 100.5 115.0 128.4
7.5 120 55.9 59.1 64.1 70.0 77.8 87.4 98.3 111.7 124.2
7.5 124 57.5 60.5 65.2 70.6 77.8 86.5 96.2 108.0 118.8
7.5 127 58.7 61.6 66.1 71.3 78.2 86.4 95.4 106.3 116.1
7.5 131 60.1 63.0 67.3 72.4 79.0 86.8 95.2 105.3 114.2
7.5 134 60.8 63.7 68.1 73.1 79.6 87.3 95.4 105.1 113.5
7.5 138 61.4 64.4 68.9 74.0 80.4 88.0 96.0 105.2 113.1
8.5 122 57.8 61.0 65.8 71.6 79.2 88.5 98.9 111.8 123.6
8.5 126 59.4 62.5 67.0 72.4 79.5 88.0 97.4 108.8 119.1
8.5 129 60.6 63.5 68.0 73.2 80.0 88.2 97.1 107.7 117.2
8.5 133 61.7 64.7 69.1 74.3 80.9 88.7 97.1 107.1 115.8
8.5 137 62.4 65.5 70.0 75.1 81.7 89.5 97.6 107.1 115.2
8.5 140 62.7 65.8 70.4 75.7 82.3 90.0 98.1 107.3 115.1
8.5 144 62.8 66.1 70.9 76.3 83.1 90.8 98.7 107.7 115.1
9.5 127 60.9 64.0 68.6 74.1 81.1 89.7 99.1 110.4 120.6
9.5 131 62.3 65.4 69.9 75.1 82.0 90.1 98.8 109.3 118.5
9.5 134 63.1 66.1 70.6 75.9 82.6 90.5 99.0 109.0 117.7
9.5 138 63.7 66.8 71.4 76.7 83.4 91.3 99.5 109.1 117.2
9.5 142 64.0 67.2 72.0 77.4 84.2 92.0 100.2 109.4 117.2
9.5 146 63.9 67.3 72.3 77.9 84.9 92.8 100.8 109.8 117.2
9.5 150 63.6 67.2 72.5 78.3 85.5 93.4 101.3 110.0 116.9
10.5 132 63.7 66.8 71.4 76.8 83.7 91.9 100.7 111.1 120.3
10.5 135 64.4 67.5 72.1 77.5 84.3 92.3 100.9 110.9 119.6
10.5 139 64.9 68.1 72.9 78.3 85.1 93.1 101.5 111.1 119.3
10.5 143 65.1 68.4 73.3 78.9 85.9 93.9 102.1 111.4 119.3
10.5 148 64.9 68.4 73.7 79.5 86.7 94.7 102.9 111.8 119.1
10.5 152 64.5 68.3 73.8 79.9 87.2 95.3 103.3 111.9 118.8
10.5 155 64.1 68.1 73.9 80.1 87.6 95.8 103.7 112.0 118.6
Abbreviation: SI, stiffness index.
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Figure 4. SI reference curves of the 1st, 50th and 99th percentiles (P) for girls and boys considering the 3rd, 50th and 97th age- and
sex-speciﬁc height percentiles.
Table 6. CTX percentile values (P) by 1-year age groups and age-
speciﬁc height percentiles (3rd, 10th, 25th, 50th, 75th, 90th and 97th)
in girls
Age
(year)
Height
(cm)
CTX percentiles—girls
P1 P3 P10 P25 P50 P75 P90 P97 P99
3.5 92 0.42 0.54 0.70 0.86 1.05 1.23 1.39 1.55 1.67
3.5 95 0.44 0.56 0.72 0.89 1.07 1.25 1.41 1.58 1.70
3.5 97 0.46 0.58 0.74 0.90 1.09 1.27 1.43 1.59 1.71
3.5 100 0.48 0.60 0.76 0.93 1.11 1.29 1.46 1.62 1.74
3.5 102 0.50 0.62 0.78 0.94 1.13 1.31 1.47 1.63 1.75
3.5 105 0.52 0.64 0.81 0.97 1.15 1.33 1.50 1.66 1.78
3.5 108 0.55 0.67 0.83 0.99 1.17 1.36 1.52 1.68 1.80
4.5 98 0.45 0.57 0.73 0.90 1.08 1.26 1.42 1.59 1.71
4.5 101 0.48 0.60 0.76 0.92 1.10 1.28 1.45 1.61 1.73
4.5 104 0.50 0.62 0.78 0.95 1.13 1.31 1.47 1.63 1.75
4.5 107 0.52 0.64 0.81 0.97 1.15 1.33 1.50 1.66 1.78
4.5 110 0.55 0.67 0.83 0.99 1.18 1.36 1.52 1.68 1.80
4.5 113 0.57 0.69 0.85 1.02 1.20 1.38 1.55 1.71 1.83
4.5 116 0.60 0.72 0.88 1.04 1.22 1.41 1.57 1.73 1.85
5.5 104 0.49 0.61 0.77 0.93 1.11 1.29 1.46 1.62 1.74
5.5 108 0.52 0.64 0.80 0.96 1.14 1.33 1.49 1.65 1.77
5.5 111 0.54 0.66 0.82 0.99 1.17 1.35 1.51 1.68 1.80
5.5 114 0.57 0.69 0.85 1.01 1.19 1.37 1.54 1.70 1.82
5.5 117 0.59 0.71 0.87 1.04 1.22 1.40 1.56 1.72 1.84
5.5 120 0.61 0.73 0.90 1.06 1.24 1.42 1.59 1.75 1.87
5.5 123 0.64 0.76 0.92 1.08 1.27 1.45 1.61 1.77 1.89
6.5 110 0.52 0.64 0.80 0.96 1.15 1.33 1.49 1.65 1.77
6.5 113 0.54 0.66 0.82 0.99 1.17 1.35 1.51 1.68 1.80
6.5 117 0.58 0.70 0.86 1.02 1.20 1.38 1.55 1.71 1.83
6.5 120 0.60 0.72 0.88 1.04 1.23 1.41 1.57 1.73 1.85
6.5 123 0.62 0.74 0.91 1.07 1.25 1.43 1.60 1.76 1.88
6.5 127 0.66 0.78 0.94 1.10 1.28 1.46 1.63 1.79 1.91
6.5 130 0.68 0.80 0.96 1.13 1.31 1.49 1.65 1.81 1.93
7.5 115 0.54 0.66 0.83 0.99 1.17 1.35 1.52 1.68 1.80
7.5 119 0.58 0.70 0.86 1.02 1.20 1.38 1.55 1.71 1.83
7.5 123 0.61 0.73 0.89 1.05 1.24 1.42 1.58 1.74 1.86
7.5 126 0.63 0.75 0.91 1.08 1.26 1.44 1.60 1.77 1.89
7.5 130 0.67 0.79 0.95 1.11 1.29 1.47 1.64 1.80 1.92
7.5 133 0.69 0.81 0.97 1.13 1.32 1.50 1.66 1.82 1.94
7.5 137 0.72 0.84 1.00 1.17 1.35 1.53 1.69 1.85 1.98
8.5 120 0.57 0.69 0.85 1.01 1.20 1.38 1.54 1.70 1.82
8.5 124 0.60 0.72 0.88 1.05 1.23 1.41 1.57 1.73 1.85
8.5 128 0.63 0.75 0.92 1.08 1.26 1.44 1.61 1.77 1.89
8.5 132 0.67 0.79 0.95 1.11 1.29 1.47 1.64 1.80 1.92
8.5 136 0.70 0.82 0.98 1.14 1.33 1.51 1.67 1.83 1.95
8.5 139 0.72 0.84 1.00 1.17 1.35 1.53 1.69 1.86 1.98
8.5 143 0.75 0.87 1.04 1.20 1.38 1.56 1.73 1.89 2.01
Abbreviation: CTX, cross-linking telopeptide of type I collagen.
Table 7. Percentile values (P) of CTX by 1-year age groups and age-
speciﬁc height percentiles (3rd, 10th, 25th, 50th, 75th, 90th and 97th)
in boys
Age
(year)
Height
(cm)
CTX percentiles—boys
P1 P3 P10 P25 P50 P75 P90 P97 P99
3.5 92 0.39 0.51 0.66 0.81 0.98 1.15 1.31 1.46 1.57
3.5 95 0.42 0.54 0.69 0.84 1.02 1.19 1.34 1.49 1.61
3.5 98 0.46 0.57 0.72 0.88 1.05 1.22 1.37 1.52 1.64
3.5 101 0.49 0.60 0.75 0.91 1.08 1.25 1.40 1.56 1.67
3.5 103 0.51 0.62 0.77 0.93 1.10 1.27 1.43 1.58 1.69
3.5 106 0.54 0.65 0.81 0.96 1.13 1.30 1.46 1.61 1.72
3.5 109 0.57 0.69 0.84 0.99 1.16 1.34 1.49 1.64 1.75
4.5 99 0.44 0.55 0.70 0.85 1.03 1.20 1.35 1.50 1.62
4.5 102 0.47 0.58 0.73 0.89 1.06 1.23 1.38 1.54 1.65
4.5 105 0.50 0.61 0.76 0.92 1.09 1.26 1.42 1.57 1.68
4.5 108 0.53 0.64 0.80 0.95 1.12 1.29 1.45 1.60 1.71
4.5 111 0.56 0.68 0.83 0.98 1.15 1.32 1.48 1.63 1.74
4.5 114 0.59 0.71 0.86 1.01 1.19 1.36 1.51 1.66 1.78
4.5 117 0.63 0.74 0.89 1.05 1.22 1.39 1.54 1.70 1.81
5.5 105 0.47 0.58 0.73 0.89 1.06 1.23 1.38 1.54 1.65
5.5 108 0.50 0.61 0.76 0.92 1.09 1.26 1.42 1.57 1.68
5.5 111 0.53 0.64 0.80 0.95 1.12 1.29 1.45 1.60 1.71
5.5 115 0.57 0.69 0.84 0.99 1.16 1.34 1.49 1.64 1.76
5.5 118 0.61 0.72 0.87 1.03 1.20 1.37 1.52 1.67 1.79
5.5 121 0.64 0.75 0.90 1.06 1.23 1.40 1.55 1.71 1.82
5.5 125 0.68 0.79 0.95 1.10 1.27 1.44 1.60 1.75 1.86
6.5 111 0.50 0.61 0.76 0.92 1.09 1.26 1.42 1.57 1.68
6.5 115 0.54 0.66 0.81 0.96 1.13 1.30 1.46 1.61 1.72
6.5 118 0.57 0.69 0.84 0.99 1.16 1.34 1.49 1.64 1.76
6.5 121 0.61 0.72 0.87 1.03 1.20 1.37 1.52 1.67 1.79
6.5 125 0.65 0.76 0.91 1.07 1.24 1.41 1.56 1.72 1.83
6.5 128 0.68 0.79 0.95 1.10 1.27 1.44 1.60 1.75 1.86
6.5 132 0.72 0.84 0.99 1.14 1.31 1.48 1.64 1.79 1.90
7.5 117 0.53 0.64 0.80 0.95 1.12 1.29 1.45 1.60 1.71
7.5 120 0.56 0.68 0.83 0.98 1.15 1.33 1.48 1.63 1.75
7.5 124 0.61 0.72 0.87 1.03 1.20 1.37 1.52 1.67 1.79
7.5 127 0.64 0.75 0.90 1.06 1.23 1.40 1.55 1.71 1.82
7.5 131 0.68 0.79 0.95 1.10 1.27 1.44 1.60 1.75 1.86
7.5 134 0.71 0.83 0.98 1.13 1.30 1.47 1.63 1.78 1.89
7.5 138 0.75 0.87 1.02 1.17 1.35 1.52 1.67 1.82 1.94
8.5 122 0.55 0.67 0.82 0.97 1.14 1.32 1.47 1.62 1.73
8.5 126 0.60 0.71 0.86 1.02 1.19 1.36 1.51 1.66 1.78
8.5 129 0.63 0.74 0.89 1.05 1.22 1.39 1.54 1.70 1.81
8.5 133 0.67 0.78 0.94 1.09 1.26 1.43 1.59 1.74 1.85
8.5 137 0.71 0.83 0.98 1.13 1.30 1.47 1.63 1.78 1.89
8.5 140 0.74 0.86 1.01 1.16 1.34 1.51 1.66 1.81 1.93
8.5 144 0.79 0.90 1.05 1.21 1.38 1.55 1.70 1.86 1.97
Abbreviation: CTX, cross-linking telopeptide of type I collagen.
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medical treatments that directly affect bone metabolism, children
with these conditions were excluded. Fat mass may also have a
pathophysiological effect on bone metabolism.2–4 This is further
supported by Eliakim et al.59 who showed reduced QUS measures
in obese compared to non-obese children. Furthermore, a
pathophysiological relationship of excessive thinness on bone
health has been reported.60 We performed sensitivity analyses to
test the robustness of the SI and CTX reference percentiles
comparing one model excluding underweight (stage 3 according
the International Obesity Task Force criteria)42 and obese children
with our main model in which these children were included. SI
and CTX values obtained from both models had only minor
deviations (Supplementary Figures A and B). Therefore, we
retained underweight and obese children in the analysis group.
Reference curves excluding underweight and obese children are
provided in (Supplementary Figures C and D).
A limitation of this study is the cross-sectional design.
Longitudinal data of individuals give more accurate reference
data. Furthermore, the lack of studies investigating long-term
sequels of low SI or inadequate CTX concentrations limits our
ability to propose risk-based cut-offs. We investigated serum CTX
as an indicator of bone metabolism. Several studies highlighted
the importance of considering more than one bone metabolic
marker, that is, at least one bone formation and resorption marker
each, for assessing reduced bone turnover or a decreased skeletal
development.15
The use of an unselected, large and heterogeneous sample of
apparently healthy European children with different living
conditions and providing data on SI and CTX using standardised
QUS, blood and anthropometric measures is a strength of the
current study. Furthermore, the large examination programme of
the IDEFICS study allowed the exclusion of children suffering from
conditions, diseases or that received medical treatments possibly
affecting bone metabolism. As an additional strength, this study is
the ﬁrst applying an improved statistical method to derive SI
and CTX reference percentiles by modelling age and height
simultaneously.
CONCLUSION
This is the ﬁrst paper providing sex-, age- and height-speciﬁc
reference values of SI and serum CTX for European children aged
2–10.9 years and 3–8.9 years, respectively, based on a large and
apparently healthy cohort. These reference values lay the ground
to evaluate bone growth and metabolism in children in
epidemiological and clinical studies. They are also of immediate
use for clinical practice in children receiving treatments that
possibly affect bone health as well as to monitor their skeletal
development. However, to apply the present reference values, the
use of different QUS brands (e.g. CUBA, Sahara, Sunlight) or CTX
assays should be considered. These reference values will be
complemented by data of adolescents participating in the follow-
up survey of the IDEFICS study (I.Family).
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